Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19

    NEXT STORY
    BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
    PREV STORY
    Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido™ (lidocaine topical system) 1.8% for PHN Pain

    SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), and ...

    author_avatar
    NASDAQ Market News

    Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

    author_avatar
    NASDAQ Market News